Driving Sustainability Through Streamlined Greenhouse-to-Grocer Operations; Aligning Technology with Company's Zero-Waste ...
"I am pleased to announce the completion of this important acquisition, bringing another well-established home energy ...
New Directors Bring Extensive Leadership Experience in Corporate Strategy and Commercialization. SEATTLE and VANCOUVER, ...
InflammX Therapeutics Inc., a clinical-stage biotechnology company focused on developing innovative therapies for retinal diseases with significant unmet needs, announced today that it has entered ...
IRADIMED CORPORATION Reports Preliminary Unaudited Record Fourth Quarter and Full-Year 2024 Revenues
Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 million Reports preliminary full-year 2024 revenue in the range of approximately $73.1 million to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback